Stellar(US) | $2,700,000 | (Jan 9, 2025)
XyloCor Therapeutics, Inc. | $67,500,000 | (Jan 9, 2025)
Aspect Biosystems | $115,000,000 | (Jan 9, 2025)
Certified by Founder
Lodge
Relief Cardiovascular
start up
United States
- Costa Mesa, CA
- 09/01/2025
- Series A
- $12,000,000
Relief Cardiovascular, an inQB8 Medical Technologies portfolio company, is creating a novel smart implant to decongest heart failure patients.
The Relief System is the world’s first transcatheter implant to both monitor and modulate renal vein pressures, offering a novel solution for managing fluid in heart failure patients – particularly for the millions of heart failure patients with diuretic resistance.
- Industry Medical Equipment Manufacturing
- Website https://www.reliefcardio.com/
- LinkedIn https://www.linkedin.com/company/relief-cardiovascular/
VitVio | $2,000,000 | (Jan 9, 2025)
Qualified Health | $30,000,000 | (Jan 9, 2025)
Evergreen Nephrology | $130,000,000 | (Jan 9, 2025)
UNLISTED | $2,250,000 | (Jan 9, 2025)
Zeto / Rapid Full-Montage EEG | $31,000,000 | (Jan 9, 2025)
Red Rover Health, Inc. | $4,000,000 | (Jan 9, 2025)
Ubiety Technologies, Inc. | $10,000,000 | (Jan 9, 2025)